Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Faherty, Christina S ^a,b   Merrell, D Scott ^a   Semino Mora, Cristina ^a   Dubois, Andre ^a   Ramaswamy, Aishwarya V ^a   Maurelli, Anthony T ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN C JUN; PROTEIN P53; RETINOBLASTOMA PROTEIN; STAUROSPORINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE PROBE; GENE SEQUENCE; GENOMIC IN SITU HYBRIDIZATION; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; SHIGELLA FLEXNERI; SHIGELLOSIS; CYTOLOGY; DNA MICROARRAY; DRUG EFFECT; HELA CELL; IN SITU HYBRIDIZATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

EUKARYOTA; SHIGELLA; SHIGELLA FLEXNERI;

APOPTOSIS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SHIGELLA FLEXNERI; STAUROSPORINE;

EID: 77951585109     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-272     Document Type: Article

References (91)

1. Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008, 21(1):134-156. 10.1128/CMR.00032-07, 2223840, 18202440.
2. Clark CS, Maurelli AT. Shigella flexneri inhibits staurosporine-induced apoptosis in epithelial cells. Infect Immun 2007, 75(5):2531-2539. 10.1128/IAI.01866-06, 1865761, 17339354.
3. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000, 157(5):1415-1430. 1885741, 11073801.
4. Pedron T, Thibault C, Sansonetti PJ. The invasive phenotype of Shigella flexneri directs a distinct gene expression pattern in the human intestinal epithelial cell line Caco-2. J Biol Chem 2003, 278(36):33878-33886. 10.1074/jbc.M303749200, 12813033.
5. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87(4):619-628. 10.1016/S0092-8674(00)81382-3, 8929531.
6. Vogt PK. Jun, the oncoprotein. Oncogene 2001, 20(19):2365-2377. 10.1038/sj.onc.1204443, 11402333.
7. Shaulian K. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4(5):E131-136. 10.1038/ncb0502-e131, 11988758.
8. Gutierrez-Venegas G, Castillo-Aleman R. Characterization of the transduction pathway involved in c-fos and c-jun expression induced by Aggregatibacter actinomycetemcomitans lipopolysaccharides in human gingival fibroblasts. Int Immunopharmacol 2008, 8(11):1513-1523. 10.1016/j.intimp.2008.06.007, 18621151.
9. Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, Worthen GS. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways. J Biol Chem 2004, 279(12):10883-10891. 10.1074/jbc.M309901200, 14699155.
10. Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene 2008, 27(3):366-377. 10.1038/sj.onc.1210643, 17637753.
11. Katabami M, Donninger H, Hommura F, Leaner VD, Kinoshita I, Chick JF, Birrer MJ. Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in RAT1a cells. J Biol Chem 2005, 280(17):16728-16738. 10.1074/jbc.M413892200, 15737994.
12. Leaner VD, Donninger H, Ellis CA, Clark GJ, Birrer MJ. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. Mol Cell Biol 2005, 25(8):3324-3337. 10.1128/MCB.25.8.3324-3337.2005, 1069594, 15798216.
13. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995, 95(1):55-65. 10.1172/JCI117676, 295369, 7814646.
14. Mizuta M, Nakajima H, Mizuta N, Kitamura Y, Nakajima Y, Hashimoto S, Matsuyama H, Shime N, Amaya F, Koh H, et al. Fas ligand released by activated monocytes causes apoptosis of lung epithelial cells in human acute lung injury model in vitro. Biol Pharm Bull 2008, 31(3):386-390. 10.1248/bpb.31.386, 18310897.
15. You Z, Ouyang H, Lopatin D, Polver PJ, Wang CY. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 2001, 276(28):26398-26404. 10.1074/jbc.M102464200, 11346652.
16. He KL, Ting AT. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol 2002, 22(17):6034-6045. 10.1128/MCB.22.17.6034-6045.2002, 133997, 12167698.
17. Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, Francke U, Reed JC, Kinoshita S, Nolan GP. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 1998, 8(4):461-471. 10.1016/S1074-7613(00)80551-8, 9586636.
18. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001, 21(16):5299-5305. 10.1128/MCB.21.16.5299-5305.2001, 87253, 11463813.
19. Mace PD, Shirley S, Day CL. Assembling the building blocks: structure and function of inhibitor of apoptosis proteins. Cell Death Differ 2010, 17(1):46-53. 10.1038/cdd.2009.45, 19373243.
20. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002, 2(9):647-656. 10.1038/nrc883, 12209154.
21. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, Herman B, Levine B. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998, 72(11):8586-8596. 110269, 9765397.
22. Thacker J, Zdzienicka MZ. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair (Amst) 2003, 2(6):655-672.
23. Reardon JT, Ge H, Gibbs E, Sancar A, Hurwitz J, Pan ZQ. Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH. Proc Natl Acad Sci USA 1996, 93(13):6482-6487. 10.1073/pnas.93.13.6482, 39049, 8692841.
24. Post SM, Tomkinson AE, Lee EY. The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase epsilon. Nucleic Acids Res 2003, 31(19):5568-5575. 10.1093/nar/gkg765, 206465, 14500819.
25. Kim PM, Allen C, Wagener BM, Shen Z, Nickoloff JA. Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. Nucleic Acids Res 2001, 29(21):4352-4360. 10.1093/nar/29.21.4352, 60192, 11691922.
26. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006, 12(9):440-450. 10.1016/j.molmed.2006.07.007, 16899408.
27. Liu SF, Lu GX, Liu G, Xing XW, Li LY, Wang Z. Cloning of a full-length cDNA of human testis-specific spermatogenic cell apoptosis inhibitor TSARG2 as a candidate oncogene. Biochem Biophys Res Commun 2004, 319(1):32-40. 10.1016/j.bbrc.2004.04.160, 15158438.
28. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 1996, 85(6):829-839. 10.1016/S0092-8674(00)81267-2, 8681378.
29. Huh K, Zhou X, Hayakawa H, Cho JY, Libermann TA, Jin J, Harper JW, Munger K. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol 2007, 81(18):9737-9747. 10.1128/JVI.00881-07, 2045412, 17609271.
30. Li H, Zhao LL, Funder JW, Liu JP. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 1997, 272(27):16729-16732. 10.1074/jbc.272.27.16729, 9201974.
31. Lee TH, Solomon MJ, Mumby MC, Kirschner MW. INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell 1991, 64(2):415-423. 10.1016/0092-8674(91)90649-J, 1846321.
32. Olsson AY, Feber A, Edwards S, Te Poele R, Giddings I, Merson S, Cooper CS. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene 2007, 26(7):1028-1037. 10.1038/sj.onc.1209854, 16909110.
33. Zhang Y, Chellappan SP. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 1995, 10(11):2085-2093.
34. Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, Muller D, Kirikae T, Jackson PK, Kotani S, et al. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell 2007, 130(4):611-623. 10.1016/j.cell.2007.06.043, 17719540.
35. Wang JY, Naderi S, Chen TT. Role of retinoblastoma tumor suppressor protein in DNA damage response. Acta Oncol 2001, 40(6):689-695. 10.1080/02841860152619098, 11765062.
36. Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT. Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol Microbiol 2009, 71(2):350-368. 10.1111/j.1365-2958.2008.06524.x, 2783611, 19017275.
37. Handa Y, Suzuki M, Ohya K, Iwai H, Ishijima N, Koleske AJ, Fukui Y, Sasakawa C. Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat Cell Biol 2007, 9(1):121-128. 10.1038/ncb1526, 17173036.
38. Fukazawa A, Alonso C, Kurachi K, Gupta S, Lesser CF, McCormick BA, Reinecker HC. GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog 2008, 4(11):e1000228. 10.1371/journal.ppat.1000228, 2583055, 19043560.
39. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281(5383):1680-1683. 10.1126/science.281.5383.1680, 9733516.
40. Zou T, Rao JN, Guo X, Liu L, Zhang HM, Strauch ED, Bass BL, Wang JY. NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am J Physiol Cell Physiol 2004, 286(5):C1009-1018. 10.1152/ajpcell.00480.2003, 15075199.
41. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278(11):8869-8872. 10.1074/jbc.C200651200, 12527755.
42. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001, 276(7):4812-4818. 10.1074/jbc.M008072200, 11087742.
43. Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 2007, 8(2):198-205. 10.1038/ni1426, 17187069.
44. Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C. Escape of intracellular Shigella from autophagy. Science 2005, 307(5710):727-731. 10.1126/science.1106036, 15576571.
45. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23(16):2891-2906. 10.1038/sj.onc.1207521, 15077152.
46. Nishina H, Sato H, Suzuki T, Sato M, Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 1990, 87(9):3619-3623. 10.1073/pnas.87.9.3619, 53953, 2110368.
47. Kantola AK, Keski-Oja J, Koli K. Induction of human LTBP-3 promoter activity by TGF-beta1 is mediated by Smad3/4 and AP-1 binding elements. Gene 2005, 363:142-150. 10.1016/j.gene.2005.07.042, 16223572.
48. Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006, 25(3):435-457. 10.1007/s10555-006-9006-2, 16951986.
49. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S, Benkirane M. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 2003, 278(4):2758-2766. 10.1074/jbc.M209572200, 12419806.
50. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996, 87(3):565-576. 10.1016/S0092-8674(00)81375-6, 8898208.
51. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 1998, 281(5379):998-1001. 10.1126/science.281.5379.998, 9703517.
52. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10(2):417-426. 10.1016/S1097-2765(02)00599-3, 12191486.
53. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129(1):45-56. 10.1016/j.cell.2007.01.045, 17418785.
54. Headon DJ, Emmal SA, Ferguson BM, Tucker AS, Justice MJ, Sharpe PT, Zonana J, Overbeek PA. Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature 2001, 414(6866):913-916. 10.1038/414913a, 11780064.
55. Yan M, Zhang Z, Brady JR, Schilbach S, Fairbrother WJ, Dixit VM. Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr Biol 2002, 12(5):409-413. 10.1016/S0960-9822(02)00687-5, 11882293.
56. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003, 11(3):577-590. 10.1016/S1097-2765(03)00050-9, 12667443.
57. Pietsch EC, Sykes SM, McMahon SB, Murphy ME. The p53 family and programmed cell death. Oncogene 2008, 27(50):6507-6521. 10.1038/onc.2008.315, 2657599, 18955976.
58. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001, 8(4):781-794. 10.1016/S1097-2765(01)00367-7, 11684014.
59. Ofek P, Ben-Meir D, Kariv-Inbal Z, Oren M, Lavi S. Cell cycle regulation and p53 activation by protein phosphatase 2C alpha. J Biol Chem 2003, 278(16):14299-14305. 10.1074/jbc.M211699200, 12514180.
60. Matsuda K, Yoshida K, Taya Y, Nakamura K, Nakamura Y, Arakawa H. p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 2002, 62(10):2883-2889.
61. Das M, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, Davis RJ. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci USA 2007, 104(40):15759-15764. 10.1073/pnas.0707782104, 2000443, 17893331.
62. Nag A, Bagchi S, Raychaudhuri P. Cul4A physically associates with MDM2 and participates in the proteolysis of p53. Cancer Res 2004, 64(22):8152-8155. 10.1158/0008-5472.CAN-04-2598, 15548678.
63. Abida WM, Nikolaev A, Zhao W, Zhang W, Gu W. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J Biol Chem 2007, 282(3):1797-1804. 10.1074/jbc.M609001200, 17098746.
64. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell 2003, 11(6):1479-1489. 10.1016/S1097-2765(03)00203-X, 12820962.
65. Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, et al. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol Cell Biol 1999, 19(3):1673-1685. 83961, 10022855.
66. Daino K, Ichimura S, Nenoi M. Both the basal transcriptional activity of the GADD45A gene and its enhancement after ionizing irradiation are mediated by AP-1 element. Biochim Biophys Acta 2006, 1759(10):458-469.
67. Woods DB, Vousden KH. Regulation of p53 function. Exp Cell Res 2001, 264(1):56-66. 10.1006/excr.2000.5141, 11237523.
68. Witte MM, Scott RE. The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation. Proc Natl Acad Sci USA 1997, 94(4):1212-1217. 10.1073/pnas.94.4.1212, 19770, 9037032.
69. Kong L, Yu XP, Bai XH, Zhang WF, Zhang Y, Zhao WM, Jia JH, Tang W, Zhou YB, Liu CJ. RbAp48 is a critical mediator controlling the transforming activity of human papillomavirus type 16 in cervical cancer. J Biol Chem 2007, 282(36):26381-26391. 10.1074/jbc.M702195200, 17616526.
70. Saijo M, Sakai Y, Kishino T, Niikawa N, Matsuura Y, Morino K, Tamai K, Taya Y. Molecular cloning of a human protein that binds to the retinoblastoma protein and chromosomal mapping. Genomics 1995, 27(3):511-519. 10.1006/geno.1995.1084, 7558034.
71. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 2005, 18(6):623-635. 10.1016/j.molcel.2005.05.012, 15949438.
72. Pugh DJ, Ab E, Faro A, Lutya PT, Hoffmann E, Rees DJ. DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathways. BMC Struct Biol 2006, 6:1. 10.1186/1472-6807-6-1, 1360078, 16396680.
73. Tonnetti L, Netzel-Arnett S, Darnell GA, Hayes T, Buzza MS, Anglin IE, Suhrbier A, Antalis TM. SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. Cancer Res 2008, 68(14):5648-5657. 10.1158/0008-5472.CAN-07-5850, 2561898, 18632617.
74. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, Koepp DM, Elledge SJ, Pagano M, et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002, 416(6882):703-709. 10.1038/416703a, 11961546.
75. Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev 1999, 13(18):2375-2387. 10.1101/gad.13.18.2375, 317026, 10500095.
76. Chen Y, McPhie DL, Hirschberg J, Neve RL. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem 2000, 275(12):8929-8935. 10.1074/jbc.275.12.8929, 10722740.
77. Chestukhin A, Pfeffer C, Milligan S, DeCaprio JA, Pellman D. Processing, localization, and requirement of human separase for normal anaphase progression. Proc Natl Acad Sci USA 2003, 100(8):4574-4579. 10.1073/pnas.0730733100, 153597, 12672959.
78. Festjens N, van Gurp M, van Loo G, Saelens X, Vandenabeele P. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematol 2004, 111(1-2):7-27. 10.1159/000074483, 14646342.
79. Johansson C, Lillig CH, Holmgren A. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 2004, 279(9):7537-7543. 10.1074/jbc.M312719200, 14676218.
80. Rikhof B, Corn PG, El-Deiry WS. Caspase 10 levels are increased following DNA damage in a p53-dependent manner. Cancer Biol Ther 2003, 2(6):707-712.
81. Filomenko R, Prevotat L, Rebe C, Cortier M, Jeannin JF, Solary E, Bettaieb A. Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells. Oncogene 2006, 25(58):7635-7645. 10.1038/sj.onc.1209733, 16767158.
82. Tang ED, Wang CY, Xiong Y, Guan KL. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 2003, 278(39):37297-37305. 10.1074/jbc.M303389200, 12867425.
83. Semino-Mora C, Doi SQ, Marty A, Simko V, Carlstedt I, Dubois A. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis 2003, 187(8):1165-1177. 10.1086/368133, 2569196, 12695995.
84. Liu H, Rahman A, Semino-Mora C, Doi SQ, Dubois A. Specific and sensitive detection of H. pylori in biological specimens by real-time RT-PCR and in situ hybridization. PLoS One 2008, 3(7):e2689. 10.1371/journal.pone.0002689, 2481290, 18648543.
85. Faherty CS, Maurelli AT. Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol 2008, 16(4):173-180. 10.1016/j.tim.2008.02.001, 2746948, 18353648.
86. Binnicker MJ, Williams RD, Apicella MA. Infection of human urethral epithelium with Neisseria gonorrhoeae elicits an upregulation of host anti-apoptotic factors and protects cells from staurosporine-induced apoptosis. Cell Microbiol 2003, 5(8):549-560. 10.1046/j.1462-5822.2003.00300.x, 12864814.
87. Danelishvili L, McGarvey J, Li YJ, Bermudez LE. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol 2003, 5(9):649-660. 10.1046/j.1462-5822.2003.00312.x, 12925134.
88. Okuda J, Arikawa Y, Takeuchi Y, Mahmoud MM, Suzaki E, Kataoka K, Suzuki T, Okinaka Y, Nakai T. Intracellular replication of Edwardsiella tarda in murine macrophage is dependent on the type III secretion system and induces an up-regulation of anti-apoptotic NF-kappaB target genes protecting the macrophage from staurosporine-induced apoptosis. Microb Pathog 2006, 41(6):226-240. 10.1016/j.micpath.2006.08.002, 17049431.
89. Bechelli JR, Rydkina E, Colonne PM, Sahni SK. Rickettsia rickettsii infection protects human microvascular endothelial cells against staurosporine-induced apoptosis by a cIAP(2)-independent mechanism. J Infect Dis 2009, 199(9):1389-1398. 10.1086/597805, 19358671.
90. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, Dwight SS, Kaloper M, Weng S, Jin H, Ball CA, et al. The Stanford Microarray Database. Nucleic Acids Res 2001, 29(1):152-155. 10.1093/nar/29.1.152, 29818, 11125075.
91. Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol 1966, 30(1):23-38. 10.1083/jcb.30.1.23, 2106982, 5338131.